The Pennant Group, Inc. - Common Stock (PNTG)
Healthcare › Services-Health Services
Price History
Feb 9, 2026 — Jul 6, 2026Investment Snapshot
- Trading 274% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 3/9 — signs of financial weakness
- ROE of 15.6% — good return on equity
- Revenue growing at 36% annually
The Pennant Group, Inc. - Common Stock (PNTG) is a Healthcare company operating in Services-Health Services, listed on the NASDAQ , with a market capitalisation of $1.1 billion . Key value metrics: P/E ratio 36.4, P/B ratio 3.12, Piotroski F-Score 3 out of 9 .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
The Pennant Group, Inc. - Common Stock — Fundamental Analysis Summary
The Pennant Group, Inc. - Common Stock (PNTG) is currently trading 274% above its Graham Number of $8.26, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 36.4x.
On financial health, PNTG shows a weak Piotroski F-Score of 3/9, a signal of deteriorating financial health, and solid return on equity of 15.6% (sector average: -20.6%), and minimal leverage with a debt-to-equity ratio of 0.08.
StockPik's composite Value Score for PNTG is 35/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
PNTG shows revenue growing at 36% year-over-year, with earnings growing at 31%.